iw-6463
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 17, 2019 (NCT03856827)
Timeline
Indications
Studied for
Mechanism of action
NPR1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04475549 | Phase 2 | Nov 13, 2020 | Cyclerion Therapeutics, Inc., University of Pennsylvania |
| NCT04240158 | Phase 1 | Jan 6, 2020 | Cyclerion Therapeutics, Inc., Leiden University |
| NCT03856827 | Phase 1 | Jan 17, 2019 | Cyclerion Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cyclerion Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2019 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1